Chemistry:Asoprisnil
From HandWiki
Short description: Chemical compound
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
Chemical and physical data | |
Formula | C28H35NO4 |
Molar mass | 449.591 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Asoprisnil (INN; developmental code name J-867) is a synthetic, steroidal selective progesterone receptor modulator that was under development by Schering and TAP Pharmaceutical Products for the treatment of uterine fibroids.[1] In 2005, phase III clinical trials were discontinued due to endometrial changes in patients.[2]
See also
References
- ↑ "Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy". Steroids 68 (10–13): 1019–32. 2003. doi:10.1016/j.steroids.2003.09.008. PMID 14667995.
- ↑ Schering Interim Report Q1-3 2005
PR |
| ||||||
---|---|---|---|---|---|---|---|
mPR (PAQR) |
| ||||||
![]() | 0.00 ![]() ![]() ![]() ![]() ![]() |